GB1158492A - Improvements in Acylated Steroids - Google Patents

Improvements in Acylated Steroids

Info

Publication number
GB1158492A
GB1158492A GB56249/66A GB5624966A GB1158492A GB 1158492 A GB1158492 A GB 1158492A GB 56249/66 A GB56249/66 A GB 56249/66A GB 5624966 A GB5624966 A GB 5624966A GB 1158492 A GB1158492 A GB 1158492A
Authority
GB
United Kingdom
Prior art keywords
optionally substituted
steroids
aryl
compositions
acylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB56249/66A
Other languages
English (en)
Inventor
John Rosindale Housley
Peter Oxley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Pure Drug Co Ltd
Original Assignee
Boots Pure Drug Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Pure Drug Co Ltd filed Critical Boots Pure Drug Co Ltd
Priority to GB56249/66A priority Critical patent/GB1158492A/en
Priority to GB30019/68A priority patent/GB1159490A/en
Priority to NO00166569A priority patent/NO127577B/no
Priority to FR94073A priority patent/FR6137M/fr
Priority to DK67267AA priority patent/DK117896B/da
Priority to NL676701919A priority patent/NL151630B/xx
Priority to FR94074A priority patent/FR1513708A/fr
Priority to SE1837/67A priority patent/SE342239B/xx
Priority to DE19671618095 priority patent/DE1618095C3/de
Priority to CH192067A priority patent/CH487134A/fr
Priority to CH590469A priority patent/CH491897A/fr
Priority to US685984A priority patent/US3506694A/en
Publication of GB1158492A publication Critical patent/GB1158492A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/913—Aspergillus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/911—Microorganisms using fungi
    • Y10S435/939—Rhizopus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GB56249/66A 1966-02-09 1966-02-09 Improvements in Acylated Steroids Expired GB1158492A (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GB56249/66A GB1158492A (en) 1966-02-09 1966-02-09 Improvements in Acylated Steroids
GB30019/68A GB1159490A (en) 1966-02-09 1966-02-09 Improvements in Acylated Steroids
NO00166569A NO127577B (enExample) 1966-02-09 1967-01-25
FR94073A FR6137M (enExample) 1966-02-09 1967-02-08
DK67267AA DK117896B (da) 1966-02-09 1967-02-08 Analogifremgangsmåde til fremstilling af 17-estere af 21-desoxyprednisolon.
NL676701919A NL151630B (nl) 1966-02-09 1967-02-08 Werkwijze ter bereiding van een farmaceutisch preparaat met anti-inflammatoire werking.
FR94074A FR1513708A (fr) 1966-02-09 1967-02-08 Procédé de préparation de 17-acyloxy-stéroïdes
SE1837/67A SE342239B (enExample) 1966-02-09 1967-02-09
DE19671618095 DE1618095C3 (de) 1966-02-09 1967-02-09 21-Desoxyprednisolon, diese enthaltende therapeutische Zubereitungen und Verfahren zu ihrer Herstellung
CH192067A CH487134A (fr) 1966-02-09 1967-02-09 Procédé de préparation d'esters de la 21-désoxyprednisolone
CH590469A CH491897A (fr) 1966-02-09 1967-02-09 Procédé de préparation de 17-acyloxy-stéroïdes
US685984A US3506694A (en) 1966-02-09 1967-11-27 17-acyloxysteroids and their manufacture

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB3001868 1966-02-09
GB56249/66A GB1158492A (en) 1966-02-09 1966-02-09 Improvements in Acylated Steroids
GB571966 1966-02-09

Publications (1)

Publication Number Publication Date
GB1158492A true GB1158492A (en) 1969-07-16

Family

ID=27254686

Family Applications (2)

Application Number Title Priority Date Filing Date
GB56249/66A Expired GB1158492A (en) 1966-02-09 1966-02-09 Improvements in Acylated Steroids
GB30019/68A Expired GB1159490A (en) 1966-02-09 1966-02-09 Improvements in Acylated Steroids

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB30019/68A Expired GB1159490A (en) 1966-02-09 1966-02-09 Improvements in Acylated Steroids

Country Status (8)

Country Link
US (1) US3506694A (enExample)
CH (1) CH487134A (enExample)
DK (1) DK117896B (enExample)
FR (2) FR6137M (enExample)
GB (2) GB1158492A (enExample)
NL (1) NL151630B (enExample)
NO (1) NO127577B (enExample)
SE (1) SE342239B (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3856956A (en) * 1967-02-02 1974-12-24 Boots Pure Drug Co Ltd 17-acyloxysteroids and their manufacture
FR2559156B1 (fr) * 1984-02-03 1989-03-24 Roussel Uclaf Procede de preparation de derives de la prednisone et produits intermediaires de ce procede
JP2655190B2 (ja) * 1989-06-21 1997-09-17 エスエス製薬 株式会社 コルチコステロイド含有軟膏剤
US6858596B2 (en) * 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
GB0019172D0 (en) * 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
KR100889426B1 (ko) 2000-08-05 2009-03-23 글락소 그룹 리미티드 항염증제로서의 6.알파.,9.알파.-디플루오로-17.알파.-'(2-푸라닐카르복실)옥시-11.베타.-히드록시-16.알파.-메틸-3-옥소-안드로스트-1,4-디엔-17-카르보티오산 ｓ-플루오로메틸 에스테르
US6777399B2 (en) * 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6759398B2 (en) * 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
AU2002253342B2 (en) * 2001-04-30 2007-01-04 Glaxo Group Limited Novel anti-inflammatory androstane derivatives
JP2005500290A (ja) * 2001-06-12 2005-01-06 グラクソ　グループ　リミテッド 抗炎症性の、１７β−カルボチオアートアンドロスタン誘導体である１７α複素環エステル
US20050175545A1 (en) * 2002-02-04 2005-08-11 Keith Biggadike Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
GB0202635D0 (en) * 2002-02-05 2002-03-20 Glaxo Wellcome Mfg Pte Ltd Formulation containing novel anti-inflammatory androstane derivative
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US7825147B2 (en) * 2003-08-29 2010-11-02 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-IV
US20070259874A1 (en) * 2003-11-26 2007-11-08 Palle Venkata P Phosphodiesterase Inhibitors
US20080009535A1 (en) * 2004-08-30 2008-01-10 Sarala Balachandran Inhibitors of phosphodiesterase type-IV
GB0507165D0 (en) * 2005-04-08 2005-05-18 Glaxo Group Ltd Novel crystalline pharmaceutical product
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
WO2007045979A1 (en) 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Pharmaceutical compositions of muscarinic receptor antagonists
BRPI0617673C1 (pt) * 2005-10-19 2012-05-22 Ranbaxy Lab Ltd composições de inibidores de fosfodiesterase do tipo iv
GB0615108D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel formulations
WO2008035315A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
EP2066661A2 (en) * 2006-09-22 2009-06-10 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
EP1958947A1 (en) 2007-02-15 2008-08-20 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type 4
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
DK2124944T3 (da) 2007-03-14 2012-04-23 Ranbaxy Lab Ltd Pyrazolo[3,4-b]pyridinderivater som phosphodiesteraseinhibitorer
EP2111861A1 (en) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
CN102372762B (zh) * 2010-08-18 2012-11-07 天津金耀集团有限公司 一种孕甾11位β羟基合成的工艺
CN107556357A (zh) * 2017-09-28 2018-01-09 湖南科瑞生物制药股份有限公司 丙酸地泼罗酮的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2923721A (en) * 1955-12-13 1960-02-02 Lab Francais Chimiotherapie Method of preparing 3-keto delta1, 4 steroids
US2902410A (en) * 1957-09-26 1959-09-01 Upjohn Co Process for the 1,2-dehydrogenation of a steroid with septomyxa

Also Published As

Publication number Publication date
FR6137M (enExample) 1968-06-24
DK117896B (da) 1970-06-15
FR1513708A (fr) 1968-02-16
NL151630B (nl) 1976-12-15
CH487134A (fr) 1970-03-15
DE1618095A1 (de) 1971-03-25
US3506694A (en) 1970-04-14
GB1159490A (en) 1969-07-23
SE342239B (enExample) 1972-01-31
DE1618095B2 (de) 1975-09-18
NO127577B (enExample) 1973-07-16
NL6701919A (enExample) 1967-08-10

Similar Documents

Publication Publication Date Title
GB1158492A (en) Improvements in Acylated Steroids
GB1174411A (en) Novel Benzothiophen Compounds, Compositions containing them and processes for their manufacture
IE32898B1 (en) Benzene derivatives
GB1178721A (en) Improvements in and relating to Novel Phenoxypropylamines
GB1184044A (en) Nitrofuryl-Oxadiazole Derivatives
IE35764B1 (en) Veterinary compositions
GB1155529A (en) Imidazole derivatives, their Preparation and Compositions containing them
GB1246117A (en) Pharmaceutical preparations containing glucose compounds, glucose derivatives and process for their manufacture
GB1186931A (en) 3-Amino-5-(Nitrofuryl)-1,2,4-Oxadiazole Derivatives
GB1269291A (en) Improvements in or relating to corticoid carbonates
GB1468079A (en) Ethanolamine derivatives
GB1168845A (en) Novel Fused-Ring Thiazine Compounds
GB1318817A (en) 21-esters of fluocinolone acetonide
GB1423761A (en) Xylidides
GB1172086A (en) Pharmaceutical preparations containing 1,2alpha-Methylene-Steroids
GB1027891A (en) Esters of dianhydro-hexitols
IE37186L (en) Benzylpyrimidines
GB1391081A (en) Optically active benzodiazepines
GB1191443A (en) Quinoline Derivatives
GB1455396A (en) 4,-o-sulphonyl-erythromycin-9-o-oxime derivatives
GB1177009A (en) Improvements in or relating to 9alpha, 11beta-Dichloro-Pregnane Compounds
GB1316702A (en) Substituted piperazine derivatives
GB1272688A (en) Sulphamido-steroids and the preparation thereof
GB1189306A (en) Improvements in or relating to Cephalosporin Antibiotics
GB1053696A (enExample)

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PE Patent expired